Vapers Digest 20th July

For decades, the message to Americans who smoked was essentially simple: quit or suffer the consequences. That message reflected the urgency of the cigarette epidemic, and the lack of alternative nicotine products available to smokers. The good news is that the marketplace, driven by innovation and science, has changed. While cigarette smoking has declined to historic lows, modern nicotine products, such as nicotine pouches and heated tobacco products, provide much better options for the legal-age adult smoker. Of course, a clear understanding of the options available is critical to making the right decision. 

This is where the FDA’s recent action on the ZYN nicotine pouch product comes in. The agency issued modified risk orders for 20 ZYN nicotine pouch products, allowing them to be marketed with a specific, FDA-authorized claim: using ZYN instead of cigarettes puts adults at lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.